CNS10-NPC-GDNF for the Treatment of ALS

Clinical trial NCT02943850 · COMPLETED

Trial details

NCT number: NCT02943850
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2017-04-01
Primary completion: 2019-10-18
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.